Market Value241,102,218
Total Holdings62
File Date2024-11-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PCVX / Vaxcyte, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
ZVRA / Zevra Therapeutics, Inc.
AMGN / Amgen Inc. Call
EFV / iShares Trust - iShares MSCI EAFE Value ETF
INSM / Insmed Incorporated
INSM / Insmed Incorporated Call
GOSS / Gossamer Bio, Inc. Call
CLDX / Celldex Therapeutics, Inc. Put
JANX / Janux Therapeutics, Inc. Put
INDV / Indivior PLC
APLT / Applied Therapeutics, Inc. Call
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock) Call
SLNO / Soleno Therapeutics, Inc. Call
IOVA / Iovance Biotherapeutics, Inc. Call
VIR / Vir Biotechnology, Inc.
QUAL / iShares Trust - iShares MSCI USA Quality Factor ETF
CLYM / Climb Bio, Inc.
BCRX / BioCryst Pharmaceuticals, Inc. Call
KROS / Keros Therapeutics, Inc.
NKTR / Nektar Therapeutics
JAZZ / Jazz Pharmaceuticals plc
RARE / Ultragenyx Pharmaceutical Inc.
RARE / Ultragenyx Pharmaceutical Inc. Call
BMY / Bristol-Myers Squibb Company
MRNA / Moderna, Inc. Call
APLS / Apellis Pharmaceuticals, Inc. Call
EWJ / iShares, Inc. - iShares MSCI Japan ETF
QQQ / Invesco QQQ Trust, Series 1
LLY / Eli Lilly and Company
CCCC / C4 Therapeutics, Inc. Call
EWU / iShares Trust - iShares MSCI United Kingdom ETF
IQLT / iShares Trust - iShares MSCI Intl Quality Factor ETF
XLU / The Select Sector SPDR Trust - The Utilities Select Sector SPDR Fund
XLP / The Select Sector SPDR Trust - The Consumer Staples Select Sector SPDR Fund
NTLA / Intellia Therapeutics, Inc.
VTV / Vanguard Index Funds - Vanguard Value ETF
SAVA / Cassava Sciences, Inc. Put
CRNX / Crinetics Pharmaceuticals, Inc.
TYRA / Tyra Biosciences, Inc.
ERAS / Erasca, Inc.
ALT / Altimmune, Inc. Call
ALT / Altimmune, Inc. Put
AMGN / Amgen Inc. Put
BPMC / Blueprint Medicines Corporation
KZR / Kezar Life Sciences, Inc.
LPTX / Leap Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
VRDN / Viridian Therapeutics, Inc. Call
CRSP / CRISPR Therapeutics AG Call
ZURA / Zura Bio Limited
ALEC / Alector, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock) Call
JANX / Janux Therapeutics, Inc.
AVDL / Avadel Pharmaceuticals plc Call
RLAY / Relay Therapeutics, Inc.
VTGN / Vistagen Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
APGE / Apogee Therapeutics, Inc.